- Home
- TOMZ vs LIXT Comparison
TOMZ vs LIXT Comparison
Compare TOMZ & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- LIXT
- Stock Information
- Founded
- TOMZ 1979
- LIXT 2005
- Country
- TOMZ United States
- LIXT United States
- Employees
- TOMZ N/A
- LIXT N/A
- Industry
- TOMZ Diversified Commercial Services
- LIXT Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- LIXT Health Care
- Exchange
- TOMZ Nasdaq
- LIXT Nasdaq
- Market Cap
- TOMZ 20.3M
- LIXT 20.5M
- IPO Year
- TOMZ N/A
- LIXT N/A
- Fundamental
- Price
- TOMZ $0.92
- LIXT $4.36
- Analyst Decision
- TOMZ Strong Buy
- LIXT
- Analyst Count
- TOMZ 1
- LIXT 0
- Target Price
- TOMZ $3.50
- LIXT N/A
- AVG Volume (30 Days)
- TOMZ 27.0K
- LIXT 135.0K
- Earning Date
- TOMZ 11-07-2025
- LIXT 11-11-2025
- Dividend Yield
- TOMZ N/A
- LIXT N/A
- EPS Growth
- TOMZ N/A
- LIXT N/A
- EPS
- TOMZ N/A
- LIXT N/A
- Revenue
- TOMZ $6,219,036.00
- LIXT N/A
- Revenue This Year
- TOMZ $18.31
- LIXT N/A
- Revenue Next Year
- TOMZ $103.30
- LIXT N/A
- P/E Ratio
- TOMZ N/A
- LIXT N/A
- Revenue Growth
- TOMZ N/A
- LIXT N/A
- 52 Week Low
- TOMZ $0.63
- LIXT $0.64
- 52 Week High
- TOMZ $1.50
- LIXT $6.26
- Technical
- Relative Strength Index (RSI)
- TOMZ 45.77
- LIXT 42.91
- Support Level
- TOMZ $0.89
- LIXT $4.18
- Resistance Level
- TOMZ $0.96
- LIXT $4.56
- Average True Range (ATR)
- TOMZ 0.04
- LIXT 0.40
- MACD
- TOMZ -0.01
- LIXT -0.07
- Stochastic Oscillator
- TOMZ 28.39
- LIXT 31.99
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.